Prontocure Pharma Private Limited
About Prontocure Pharma Private Limited
Data last updated:
Prontocure Pharma Private Limited is a private limited company based in Rajkot, Gujarat, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 02 November 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U51909GJ2018PTC105083. Its GSTIN is 24AAKCP1845R1ZT (Gujarat).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Bhupatbhai Desai and Ashrutiben Niteshkumar Hirapara.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Rajkot, Gujarat.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.17 Cr, a growth of 49% compared to the previous year. For the same year it recorded a net profit of ₹28.88 Lakh (net margin 9.1%) and EBITDA of ₹31.68 Lakh (EBITDA margin 10%). Revenue has grown at a compounded annual rate (CAGR) of 23% over three years and 19% over five years.
The company has about 1 employee on its provident fund (EPFO) records.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressThe Corporate World Office No., 415/416 Opposite Suvarnabhoomi Complex, Rajkot, Gujarat, India – 360005
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Prontocure Pharma Private Limited
The main business activity of Prontocure Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Prontocure Pharma Private Limited FY 2025 filings available
Prontocure Pharma Private Limited reported revenue of ₹3.17 Cr (up 49% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Prontocure Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 19% over five years, including 49% growth in the latest year. EBITDA rose 174% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Prontocure Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹31.68 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹28.88 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Prontocure Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 9.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Prontocure Pharma are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Prontocure Pharma Private Limited
Prontocure Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Neets Pharma Private Limited | ₹3.18 Cr (FY 2024) | •••• | •••• | -7.0% | •••• | Paithan, Maharashtra, India |
| Kozon India Solutions (OPC) Private Limited | ₹3.18 Cr (FY 2024) | •••• | •••• | 117.0% | •••• | New Delhi, Delhi, India |
| Northern Industrial Chemical and Pharmaceuticals Private Limited | ₹3.17 Cr (FY 2025) | •••• | •••• | -7.0% | •••• | Bhopal, Madhya Pradesh, India |
| Spiceor Bionutralites Private Limited | ₹3.17 Cr (FY 2023) | •••• | •••• | -36.0% | •••• | Ernakulam, Kerala, India |
| Nuberg Pharmaceuticals Private Limited | ₹3.17 Cr (FY 2025) | •••• | •••• | -2.0% | •••• | Mohali, Punjab, India |
| Prontocure Pharma Private Limited this company | ₹3.17 Cr (FY 2025) | •••• | •••• | 49.0% | •••• | Rajkot, Gujarat, India |
| S M Cosmetics Private Limited | ₹3.16 Cr (FY 2025) | •••• | •••• | 24.0% | •••• | Ludhiana, Punjab, India |
| J. P. Life Science Private Limited | ₹3.16 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Ahmedabad, Gujarat, India |
| Bison Pharma Private Limited | ₹3.15 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Punjab, India |
| Glendale Organics Private Limited | ₹3.15 Cr (FY 2023) | •••• | •••• | 1805.0% | •••• | Mumbai, Maharashtra, India |
| Catalyst Speciality Chemicals Private Limited | ₹3.15 Cr (FY 2018) | •••• | •••• | -63.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Prontocure Pharma by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Prontocure Pharma Private Limited
Prontocure Pharma Private Limited is audited by H T A AND ASSOCIATES for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| H T A AND ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Prontocure Pharma Private Limited
Prontocure Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhupatbhai Desai Also directs: Rich Root Bio-Chem Private Limited | Director | 02 Nov 2018 | 7 Years 11 Months | Current |
| Ashrutiben Niteshkumar Hirapara | Director | 02 Nov 2018 | 7 Years 11 Months | Current |
| Bhavesh Janakray Dave | Director | 02 Nov 2018 | 7 Years 11 Months | Current |
Ownership and Shareholding of Prontocure Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Prontocure Pharma Private Limited
Prontocure Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Prontocure Pharma Private Limited
Prontocure Pharma Private Limited has a workforce of 1 employees as of Apr 08, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Prontocure Pharma Private Limited
Prontocure Pharma Private Limited has 3 board changes on record since 2018: 3 appointments. The latest: Ashrutiben Niteshkumar Hirapara was appointed as Director on 02 Nov 2018.
Credit Ratings, Litigation & Regulatory Alerts for Prontocure Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Prontocure Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Prontocure Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Prontocure Pharma Private Limited
Prontocure Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAKCP1845R1ZT | Gujarat | Active | 13 Dec 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Prontocure Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Prontocure Pharma Private Limited
Prontocure Pharma is an active private limited company based in Rajkot, Gujarat, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 02 November 2018 (8+ years old) and is registered under CIN U51909GJ2018PTC105083.
Prontocure Pharma reported revenue of ₹3.17 Cr for FY 2025 (up 49% YoY).
Prontocure Pharma has 3 current directors:
- Bhupatbhai Desai - Director
- Ashrutiben Niteshkumar Hirapara - Director
- Bhavesh Janakray Dave - Director
Prontocure Pharma reported a net profit of ₹28.88 Lakh (net margin 9.1%) and EBITDA of ₹31.68 Lakh (EBITDA margin 10%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Prontocure Pharma is 23% over three years and 19% over five years. In the latest year (FY 2025) revenue rose 49%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Prontocure Pharma is 24AAKCP1845R1ZT, registered in Gujarat.
The CIN (Corporate Identification Number) of Prontocure Pharma is U51909GJ2018PTC105083. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Prontocure Pharma was incorporated on 02 November 2018, making it 8+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Prontocure Pharma by revenue are Neets Pharma Private Limited, Kozon India Solutions (OPC) Private Limited, Northern Industrial Chemical and Pharmaceuticals Private Limited, Spiceor Bionutralites Private Limited, Nuberg Pharmaceuticals Private Limited and 5 more, all in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ashrutiben Niteshkumar Hirapara was appointed as Director on 02 Nov 2018. Bhavesh Janakray Dave was appointed as Director on 02 Nov 2018. Bhupatbhai Desai was appointed as Director on 02 Nov 2018.
The registered office of Prontocure Pharma is at The Corporate World Office No., 415416 Opposite Suvarnabhoomi Complex, Rajkot, Gujarat, India – 360005.